Article By:
Zacks Investment Research
Saturday, March 13, 2021 4:15 PM EDT
Novavax NVAX is a formidable name on the list of companies, which are developing a COVID-19 vaccine. Here are a few ETFs that are exposed to Novavax, which was up around 22% in after-hour trading after the announcement of encouraging vaccine data.